Recombinant cytomegalovirus vaccine
US5591439A · kind A · utility
43Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 1995 |
| Grant date | Jan 7, 1997 |
| Priority date | — |
| Expiry date | Apr 21, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2810/6018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being useful as a vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.